Literature DB >> 30611802

Progress in brain cannabinoid CB2 receptor research: From genes to behavior.

Chloe J Jordan1, Zheng-Xiong Xi2.   

Abstract

The type 2 cannabinoid receptor (CB2R) was initially regarded as a peripheral cannabinoid receptor. However, recent technological advances in gene detection, alongside the availability of transgenic mouse lines, indicate that CB2Rs are expressed in both neurons and glial cells in the brain under physiological and pathological conditions, and are involved in multiple functions at cellular and behavioral levels. Brain CB2Rs are inducible and neuroprotective via up-regulation in response to various insults, but display species differences in gene and receptor structures, CB2R expression, and receptor responses to various CB2R ligands. CB2R transcripts also differ between the brain and spleen. In the brain, CB2A is the major transcript isoform, while CB2A and CB2B transcripts are present at higher levels in the spleen. These new findings regarding brain versus spleen CB2R isoforms may in part explain why early studies failed to detect brain CB2R gene expression. Here, we review evidence supporting the expression and function of brain CB2R from gene and receptor levels to cellular functioning, neural circuitry, and animal behavior.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Brain CB2 receptors; Cannabinoids; Neuronal CB2 receptors; VTA dopamine neurons; deltaΔ(9)-THC(9)-

Mesh:

Substances:

Year:  2019        PMID: 30611802      PMCID: PMC6401261          DOI: 10.1016/j.neubiorev.2018.12.026

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  145 in total

Review 1.  The endocannabinoid system and the brain.

Authors:  Raphael Mechoulam; Linda A Parker
Journal:  Annu Rev Psychol       Date:  2012-07-12       Impact factor: 24.137

2.  The inhibitory action of exo- and endocannabinoids on [³H]GABA release are mediated by both CB₁and CB₂receptors in the mouse hippocampus.

Authors:  Rómeó D Andó; Judit Bíró; Cecília Csölle; Catherine Ledent; Beáta Sperlágh
Journal:  Neurochem Int       Date:  2011-11-22       Impact factor: 3.921

3.  Expression of the cannabinoid CB2 receptor in the rat cerebellum: an immunohistochemical study.

Authors:  John C Ashton; Deborah Friberg; Cynthia L Darlington; Paul F Smith
Journal:  Neurosci Lett       Date:  2005-12-13       Impact factor: 3.046

4.  Pharmacological characterization of the cannabinoid receptor 2 agonist, β-caryophyllene on seizure models in mice.

Authors:  Jana Tchekalarova; Keylla da Conceição Machado; Antonio Luiz Gomes Júnior; Ana Amélia de Carvalho Melo Cavalcante; Albena Momchilova; Rumyana Tzoneva
Journal:  Seizure       Date:  2018-03-12       Impact factor: 3.184

5.  Antipsychotic-like Effects of M4 Positive Allosteric Modulators Are Mediated by CB2 Receptor-Dependent Inhibition of Dopamine Release.

Authors:  Daniel J Foster; Jermaine M Wilson; Daniel H Remke; M Suhaib Mahmood; M Jashim Uddin; Jürgen Wess; Sachin Patel; Lawrence J Marnett; Colleen M Niswender; Carrie K Jones; Zixiu Xiang; Craig W Lindsley; Jerri M Rook; P Jeffrey Conn
Journal:  Neuron       Date:  2016-09-08       Impact factor: 17.173

6.  Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice.

Authors:  A Zimmer; A M Zimmer; A G Hohmann; M Herkenham; T I Bonner
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

7.  Cannabinoid-Induced Tetrad in Mice.

Authors:  Mathilde Metna-Laurent; Miguel Mondésir; Agnès Grel; Monique Vallée; Pier-Vincenzo Piazza
Journal:  Curr Protoc Neurosci       Date:  2017-07-05

8.  CB1 Receptor Activation on VgluT2-Expressing Glutamatergic Neurons Underlies Δ9-Tetrahydrocannabinol (Δ9-THC)-Induced Aversive Effects in Mice.

Authors:  Xiao Han; Yi He; Guo-Hua Bi; Hai-Ying Zhang; Rui Song; Qing-Rong Liu; Josephine M Egan; Eliot L Gardner; Jing Li; Zheng-Xiong Xi
Journal:  Sci Rep       Date:  2017-09-26       Impact factor: 4.379

9.  Anti-Obesity Effect of the CB2 Receptor Agonist JWH-015 in Diet-Induced Obese Mice.

Authors:  A N A Verty; A Stefanidis; A J McAinch; D H Hryciw; Brian Oldfield
Journal:  PLoS One       Date:  2015-11-20       Impact factor: 3.240

10.  CB2 Cannabinoid Receptor Knockout in Mice Impairs Contextual Long-Term Memory and Enhances Spatial Working Memory.

Authors:  Yong Li; Jimok Kim
Journal:  Neural Plast       Date:  2015-12-27       Impact factor: 3.599

View more
  47 in total

1.  Xie2-64, a novel CB2 receptor inverse agonist, reduces cocaine abuse-related behaviors in rodents.

Authors:  Chloe J Jordan; Zhi-Wei Feng; Ewa Galaj; Guo-Hua Bi; Ying Xue; Ying Liang; Terence McGuire; Xiang-Qun Xie; Zheng-Xiong Xi
Journal:  Neuropharmacology       Date:  2020-07-24       Impact factor: 5.250

2.  Different receptor mechanisms underlying phytocannabinoid- versus synthetic cannabinoid-induced tetrad effects: Opposite roles of CB1 /CB2 versus GPR55 receptors.

Authors:  Xiao-Fei Wang; Ewa Galaj; Guo-Hua Bi; Cindy Zhang; Yi He; Jia Zhan; Michael H Bauman; Eliot L Gardner; Zheng-Xiong Xi
Journal:  Br J Pharmacol       Date:  2020-02-11       Impact factor: 8.739

3.  Δ8 -Tetrahydrocannabivarin has potent anti-nicotine effects in several rodent models of nicotine dependence.

Authors:  Zheng-Xiong Xi; Pretal Muldoon; Xiao-Fei Wang; Guo-Hua Bi; M Imad Damaj; Aron H Lichtman; Roger G Pertwee; Eliot L Gardner
Journal:  Br J Pharmacol       Date:  2019-10-28       Impact factor: 8.739

Review 4.  Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders.

Authors:  Ewa Galaj; Zheng-Xiong Xi
Journal:  CNS Drugs       Date:  2019-10       Impact factor: 5.749

5.  The impact of cannabinoid type 2 receptors (CB2Rs) in neuroprotection against neurological disorders.

Authors:  Qing Xin; Fei Xu; Devin H Taylor; Jing-Fu Zhao; Jie Wu
Journal:  Acta Pharmacol Sin       Date:  2020-10-06       Impact factor: 6.150

6.  Cannabinoid CB2 Receptor Modulation by the Transcription Factor NRF2 is Specific in Microglial Cells.

Authors:  M Galán-Ganga; R Del Río; N Jiménez-Moreno; M Díaz-Guerra; I Lastres-Becker
Journal:  Cell Mol Neurobiol       Date:  2019-08-05       Impact factor: 5.046

7.  Cannabinoid CB2 receptors are expressed in glutamate neurons in the red nucleus and functionally modulate motor behavior in mice.

Authors:  Hai-Ying Zhang; Hui Shen; Ming Gao; Zegang Ma; Briana J Hempel; Guo-Hua Bi; Eliot L Gardner; Jie Wu; Zheng-Xiong Xi
Journal:  Neuropharmacology       Date:  2021-03-28       Impact factor: 5.250

8.  Cannabinoid CB2 receptors mediate the anxiolytic-like effects of monoacylglycerol lipase inhibition in a rat model of predator-induced fear.

Authors:  Devon Ivy; Francesca Palese; Valentina Vozella; Yannick Fotio; Aylin Yalcin; Gina Ramirez; David Mears; Gary Wynn; Daniele Piomelli
Journal:  Neuropsychopharmacology       Date:  2020-05-06       Impact factor: 7.853

9.  International Association for the Study of Pain Presidential Task Force on Cannabis and Cannabinoid Analgesia: research agenda on the use of cannabinoids, cannabis, and cannabis-based medicines for pain management.

Authors:  Simon Haroutounian; Lars Arendt-Nielsen; Joletta Belton; Fiona M Blyth; Louisa Degenhardt; Marta Di Forti; Christopher Eccleston; David P Finn; Nanna B Finnerup; Emma Fisher; Alexandra E Fogarty; Ian Gilron; Andrea G Hohmann; Eija Kalso; Elliot Krane; Mohammed Mohiuddin; R Andrew Moore; Michael Rowbotham; Nadia Soliman; Mark Wallace; Nantthasorn Zinboonyahgoon; Andrew S C Rice
Journal:  Pain       Date:  2021-07-01       Impact factor: 6.961

10.  Repeated cocaine administration upregulates CB2 receptor expression in striatal medium-spiny neurons that express dopamine D1 receptors in mice.

Authors:  Hai-Ying Zhang; Lindsay De Biase; Ramesh Chandra; Hui Shen; Qing-Rong Liu; Eliot Gardner; Mary Kay Lobo; Zheng-Xiong Xi
Journal:  Acta Pharmacol Sin       Date:  2021-07-27       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.